"Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

The mega-blockbuster weight loss GLP-1 drug is now also approved to treat obstructive sleep apnea in adults with obesity, in ...

Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

Obstructive sleep apnea happens when a person's upper airway becomes blocked ... to half of apnea patients either quit using a continuous positive airway pressure machine or never fill their ...

If you have sleep apnea and obesity, tirzepatide Zepbound may offer relief and support weight loss. Ask your doctor if it’s a ...

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating ...

"Too often, obstructive sleep apnea is brushed off as 'just snoring' — but it's far more than that," said Julie Flygare, CEO ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.